# NCT02454972 (NCT02454972)

> Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02454972
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: PharmaMar
- Conditions: Advanced Solid Tumors
- Interventions: lurbinectedin (PM01183)
- Enrollment: 345
- Primary outcome: Overall Response Rate (ORR)
- Primary outcome: Response by Investigator Assessment

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct02454972